Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-12-17 Purchase |
2021-12-20 6:30 pm |
Galera Therapeutics Inc. | GRTX | West Linda Director |
20,000 | $2.7402 | $54,804 | 60,000 (Direct) |
View |
2021-09-01 Sale |
2021-09-03 4:31 pm |
Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer |
47,756 | $8.4701 | $404,498 | 61,142 (Direct) |
View |
2021-06-15 Purchase |
2021-06-17 6:41 pm |
Galera Therapeutics Inc. | GRTX | West Linda Director |
10,000 | $9.13 | $91,300 | 49,888 (Direct) |
View |
2021-06-02 Purchase |
2021-06-04 8:13 pm |
Galera Therapeutics Inc. | GRTX | West Linda Director |
10,000 | $8.6511 | $86,511 | 30,000 (Direct) |
View |
2021-06-01 Purchase |
2021-06-03 5:22 pm |
Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director |
4,045 | $8.5887 | $34,741 | 10,370 (Indirect Direct) |
View |
2021-05-28 Purchase |
2021-06-02 5:35 pm |
Galera Therapeutics Inc. | GRTX | West Linda Director |
20,000 | $8.6395 | $172,791 | 20,000 (Direct) |
View |
2021-02-18 Sale |
2021-02-19 5:20 pm |
Galera Therapeutics Inc. | GRTX | Novo Holdings A/S 10% Owner |
500,000 | $10.58 | $5,290,000 | 2,459,021 (Direct) |
View |
2020-11-13 Purchase |
2020-11-17 4:06 pm |
Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director |
2,325 | $10.22 | $23,771 | 6,325 (Direct) |
View |
2020-11-12 Sale |
2020-11-16 7:46 pm |
Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer |
20,000 | $10.19 | $203,824 | 35,844 (Direct) |
View |
2020-10-26 Sale |
2020-10-28 5:56 pm |
Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer |
2,244 | $15 | $33,660 | 108,898 (Direct) |
View |
2020-10-15 Sale |
2020-10-19 4:34 pm |
Galera Therapeutics Inc. | GRTX | Novo Holdings A/S 10% Owner |
450,000 | $11 | $4,950,000 | 2,959,021 (Direct) |
View |
2020-10-05 Sale |
2020-10-07 5:01 pm |
Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer |
10,636 | $12 | $127,632 | 4,904 (Direct) |
View |
2020-06-18 Sale |
2020-06-22 4:52 pm |
Galera Therapeutics Inc. | GRTX | Novartis Bioventures Ltd NOVARTIS AG Former 10% Owner |
1,002,212 | $8.2507 | $8,268,960 | 2,467,961 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-06-15 Option Award |
2022-06-16 4:05 pm |
N/A 2032-06-14 |
Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director |
20,000 | $0 | 20,000 (Direct) |
View |
2022-06-15 Option Award |
2022-06-16 4:05 pm |
N/A 2032-06-14 |
Galera Therapeutics Inc. | GRTX | Cunningham Emmett Director |
15,000 | $0 | 0 (Direct) |
View |
2022-02-28 Option Award |
2022-03-02 4:06 pm |
N/A 2032-02-27 |
Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2022-02-28 Option Award |
2022-03-02 4:06 pm |
N/A 2032-02-27 |
Galera Therapeutics Inc. | GRTX | Stacey Jennifer Evans See Remarks |
75,000 | $0 | 75,000 (Direct) |
View |
2022-02-28 Option Award |
2022-03-02 4:05 pm |
N/A 2032-02-27 |
Galera Therapeutics Inc. | GRTX | Degnan Chris Chief Financial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
2022-02-28 Option Award |
2022-03-02 4:05 pm |
N/A 2032-02-27 |
Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2022-02-28 Option Award |
2022-03-02 4:05 pm |
N/A 2032-02-27 |
Galera Therapeutics Inc. | GRTX | Bachleda Mark Chief Commercial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2022-02-28 Option Award |
2022-03-02 4:05 pm |
N/A 2032-02-27 |
Galera Therapeutics Inc. | GRTX | Sorensen Mel President and CEO |
264,400 | $0 | 264,400 (Direct) |
View |
2021-12-17 Exercise |
2021-12-20 6:30 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer |
20,000 | $1.07 | 183,842 (Direct) |
View |
2021-12-17 Exercise |
2021-12-20 6:30 pm |
N/A 2022-11-25 |
Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer |
20,000 | $0 | 183,842 (Direct) |
View |
2021-10-08 Option Award |
2021-10-12 8:23 pm |
N/A 2031-10-07 |
Galera Therapeutics Inc. | GRTX | Bachleda Mark Chief Commercial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2021-10-08 Option Award |
2021-10-12 8:20 pm |
N/A 2031-10-07 |
Galera Therapeutics Inc. | GRTX | Stacey Jennifer Evans See Remarks |
130,000 | $0 | 130,000 (Direct) |
View |
2021-09-01 Exercise |
2021-09-03 4:31 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer |
47,756 | $2.43 | 61,142 (Direct) |
View |
2021-09-01 Exercise |
2021-09-03 4:31 pm |
N/A 2026-03-31 |
Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer |
47,756 | $0 | 61,142 (Direct) |
View |
2021-07-01 Option Award |
2021-07-06 6:16 pm |
N/A 2031-06-30 |
Galera Therapeutics Inc. | GRTX | West Linda Director |
8,730 | $0 | 8,730 (Direct) |
View |
2021-07-01 Option Award |
2021-07-06 6:15 pm |
N/A 2031-06-30 |
Galera Therapeutics Inc. | GRTX | Cunningham Emmett Director |
5,408 | $0 | 0 (Direct) |
View |
2021-07-01 Option Award |
2021-07-06 6:15 pm |
N/A 2031-06-30 |
Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director |
8,498 | $0 | 8,498 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 6:42 pm |
N/A 2031-06-15 |
Galera Therapeutics Inc. | GRTX | LOKAY KEVIN G Director |
9,888 | $0 | 9,888 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 6:41 pm |
N/A 2031-06-15 |
Galera Therapeutics Inc. | GRTX | Alleva Lawrence M Director |
9,888 | $0 | 9,888 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 6:41 pm |
N/A 2031-06-15 |
Galera Therapeutics Inc. | GRTX | West Linda Director |
9,888 | $0 | 49,888 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 6:39 pm |
N/A 2031-06-15 |
Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director |
13,179 | $0 | 13,179 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 6:36 pm |
N/A 2031-06-15 |
Galera Therapeutics Inc. | GRTX | Cunningham Emmett Director |
9,888 | $0 | 0 (Direct) |
View |
2021-03-26 Exercise |
2021-03-30 4:42 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | Sorensen Mel President and CEO |
46,940 | $1.14 | 232,044 (Direct) |
View |
2021-03-26 Exercise |
2021-03-30 4:42 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | Sorensen Mel President and CEO |
170,075 | $1.07 | 232,044 (Direct) |
View |
2021-03-26 Exercise |
2021-03-30 4:42 pm |
N/A 2022-11-25 |
Galera Therapeutics Inc. | GRTX | Sorensen Mel President and CEO |
217,015 | $0 | 232,044 (Direct) |
View |
2021-01-26 Option Award |
2021-01-28 4:05 pm |
N/A 2031-01-25 |
Galera Therapeutics Inc. | GRTX | Degnan Chris Chief Financial Officer |
82,500 | $0 | 82,500 (Direct) |
View |
2021-01-26 Option Award |
2021-01-28 4:05 pm |
N/A 2031-01-25 |
Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer |
50,000 | $0 | 50,000 (Direct) |
View |
2021-01-26 Option Award |
2021-01-28 4:05 pm |
N/A 2031-01-25 |
Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer |
71,250 | $0 | 71,250 (Direct) |
View |
2021-01-26 Option Award |
2021-01-28 4:05 pm |
N/A 2031-01-25 |
Galera Therapeutics Inc. | GRTX | Beardsley Robert A Chief Operating Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2021-01-26 Option Award |
2021-01-28 4:05 pm |
N/A 2031-01-25 |
Galera Therapeutics Inc. | GRTX | Sorensen Mel President and CEO |
190,000 | $0 | 190,000 (Direct) |
View |
2021-01-26 Option Award |
2021-01-28 4:05 pm |
N/A 2031-01-25 |
Galera Therapeutics Inc. | GRTX | Fratamico Arthur Chief Business Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2020-11-13 Exercise |
2020-11-16 7:46 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer |
2,639 | $2.43 | 35,844 (Direct) |
View |
2020-11-13 Exercise |
2020-11-16 7:46 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer |
3,755 | $1.14 | 35,844 (Direct) |
View |
2020-11-12 Exercise |
2020-11-16 7:46 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer |
13,606 | $1.07 | 35,844 (Direct) |
View |
2020-11-12 Exercise |
2020-11-16 7:46 pm |
N/A 2023-01-22 |
Galera Therapeutics Inc. | GRTX | Sussman Joel F. Chief Accounting Officer |
20,000 | $0 | 35,844 (Direct) |
View |
2020-10-26 Exercise |
2020-10-28 5:56 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer |
2,244 | $2.43 | 108,898 (Direct) |
View |
2020-10-26 Exercise |
2020-10-28 5:56 pm |
N/A 2026-03-31 |
Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer |
2,244 | $0 | 108,898 (Direct) |
View |
2020-10-06 Exercise |
2020-10-07 5:01 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer |
5,632 | $1.14 | 4,904 (Direct) |
View |
2020-10-05 Exercise |
2020-10-07 5:01 pm |
N/A N/A |
Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer |
5,004 | $1.07 | 4,904 (Direct) |
View |
2020-10-05 Exercise |
2020-10-07 5:01 pm |
N/A 2023-01-26 |
Galera Therapeutics Inc. | GRTX | HOLMLUND JON T Chief Medical Officer |
10,636 | $0 | 4,904 (Direct) |
View |